Save the Date: BC Biotechnology Awards Nominations Now OpenBC Biotech is proud to be hosting our 9th Annual BC Biotechnology Awards Ceremony on Wednesday, April 18, 2007 to honour outstanding contributions made by members of British Columbia's biotechnology community. This event has evolved to become the premier evening of the year for biotech in BC, and we hope to have you all join us in this year's celebration. You all know a deserving member of British Columbia's biotechnology community, so we ask you to make sure they are nominated! The nomination process is open to BC Biotech members and non-members alike, and you may nominate another company or person you feel is deserving, or submit an application for your own company. For more information about the BC Biotechnology Awards contact Barry Gee, Director, Operations and Communications at (604) 602-5226 or bgee@bcbiotech.ca The 9th Annual BC Biotechnology Awards are presented by:
BC Biotech in partnership with JETRO Vancouver was pleased to organize a partnering day with Takeda Research Investment, Inc. (TRI) on November 14th. Dr. Yuji Iizawa, Senior Vice President and Dr. Hiroya Muranishi, Manager of Scientific Evaluation visited Vancouver and met with six of our member organizations to discuss partnerships and investment opportunities. TRI is based in Palo Alto, California and is actively seeking global investment opportunities. Their goal is to place $100 million in investments during the next 4-5 years, with an immediate emphasis on cardiovascular, central nervous system, metabolic and oncology therapeutic domains. The scope of the fund does not include diagnostics, devices, gene therapy or anti-infective products. TRI's visit to British Columbia consisted of meetings and site visits with our organizations focusing their efforts in the therapeutics listed above, and included the Centre for Drug Research & Development, Allon Therapeutics, The Diabetes Group, Neuromed Pharmaceuticals, Somapath Pharmaceuticals and Welichem Biotech Inc. In October, Xenon Pharmaceuticals, a biopharmaceutical company located in Burnaby, and Takeda Pharmaceutical Company Limited announced an exclusive agreement to develop and commercialize oral formulations of Xenon’s lead product for pain, XEN401, in Japan and certain Asian countries. In the coming months, we hope to see that the meetings with TRI lead to similar agreements and partnerships between the Japanese firm and our local biotech companies. BC Biotech would like to thank JETRO Vancouver and UBC UILO for their assistance in organizing this very successful partnering day.
BC Biotech at BioPartnering Europe (BPE)In alignment with BC Biotech's strategic objective of raising our industry profile and facilitating partnering, we are pleased to announce that British Columbia had a significant presence at the 15th Annual BioPartnering Europe Conference in London, UK this year. BC Biotech represented our industry in British Columbia, and six BC Biotech member companies presented during the conference. The companies include Aspreva Pharmaceuticals, Clera Inc., Chemokine Therapeutics, Novation Pharmaceuticals, Perceptronix Medical Inc and Welichem Biotech Inc. BioPartnering Europe is one of the leading independent partnering events, and is intended to close the ties between North American and European biotechnology companies. BPE provides the opportunity to meet strategic international partners and attracts top pharmaceutical, biotechnology, financial and service companies from around the world.
BioPartnering North America (BPN) is one of the leading international partnering conferences for the life sciences. Annually co-hosted by BC Biotech, BioAlberta & BIOTECanada, BioPartnering North America consistently attracts top decision makers from leading pharmaceutical, biotechnology, service and financial companies. The conference is held from February 4-6, 2007 in Vancouver, B.C., Canada at the Westin Bayshore Resort. Register Early and Save -Register by January 2, 2007 and save over 20% off the regular registration rate!
For more information or to register online, visit http://www.techvision.com/bpn/
Presenting company applications are now being accepted and reviewed for both the Emerging Company and Open House presentations. BPN offers two presentation formats, each providing a specialized focus. The presenter selection process has already begun and applications are reviewed on a first-come, first-served basis.
Click here to apply to present at BioPartnering North America. For more information on presenting your company at BioPartnering North America, please contact Lila Taylor at ltaylor@techvision.com
Book Your Advertising Space Now in the 2007 Biotechnology in BC and Corporate Profiles!Biotechnology in BC is BC Biotech's annual magazine published by Business in Vancouver Media Group (BIV) and is widely distributed to reach biotech and other business professionals around the world. BIV is also the publisher of our Corporate Profiles supplement which showcases all our BC Biotech companies by therapeutic interest. Both these publications are a great vehicle for promoting BC's biotechnology sector, and a great way to show your support for your industry. Click here for more details and to book your space now!
Past winners have included Dr. Bill Hunter and Dr. Lindsay Machan of Angiotech Pharmaceuticals, Dr. Michael Smith and Rick Hansen. BC Biotech would like to ask our membership and the biotechnology community to nominate a deserving company for this years Awards and put BC in the spotlight again. |
||||||
 Suite 900 - 1188 West Georgia St.
Vancouver, BC V6E 4A2 |